The top 10 health stories of 2006.
D000911:Antibodies, Monoclonal / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D035843:Biomedical Research / Q000639:trends*; D019496:Cancer Vaccines / Q000276:immunology; D017277:Drug Approval / Q000379:methods; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D007251:Influenza, Human / Q000517:prevention & control; D008268:Macular Degeneration / Q000628:therapy; D008297:Male; D008404:Massachusetts; D017057:Medically Uninsured / Q000331:legislation & jurisprudence; D000069442:Natalizumab; D009369:Neoplasms / Q000517:prevention & control; D009936:Organizational Innovation; D053918:Papillomavirus Vaccines / Q000276:immunology; D044242:Trans Fatty Acids / Q000008:administration & dosage / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control; D014765:Viral Vaccines / Q000276:immunology; D014807:Vitamin D / Q000502:physiology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D019496:Cancer Vaccines; D000069442:Natalizumab; D053918:Papillomavirus Vaccines; D044242:Trans Fatty Acids; D014765:Viral Vaccines; D014807:Vitamin D